Open AccessAwareness of physicians and clinical pharmacists about ACC/AHA guidelines for dyslipidemia management: A cross sectional study
Author(s) -
Mohammad F Zaitoun,
Mais Hasan Iflaifel,
Loloah Abdullah Almulhim,
Mohammed Alghamdi,
Yasir Ahmed Ibrahim
Publication year - 2019
Publication title -
journal of pharmacy and bioallied sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 36
eISSN - 0976-4879
pISSN - 0975-7406
DOI - 10.4103/jpbs.jpbs_59_18
Subject(s) - dyslipidemia , medicine , family medicine , cross sectional study , clinical practice , clinical pharmacy , pharmacist , health care , cronbach's alpha , pharmacy , obesity , pathology , clinical psychology , economics , economic growth , psychometrics
Cardiovascular diseases (CVDs) are one of the leading causes of morbidity and mortality worldwide. Although genetics could contribute to the incidence of CVD, they are mostly acquired conditions. Management of precipitating factors such as hyperlipidemia can prevent CVD. Therefore, clinical guidelines have been used as a tool to improve patient outcomes and minimize practice variation.